Taylor, J. and Krska, J. and MacKridge, A. (2012) A community pharmacy-based cardiovascular screening service: Views of service users and the public. International Journal of Pharmacy Practice, 20 (5). pp. 277-284. ISSN 0961-7671.
|The full text of this publication is not available from this repository. (Contact us about this Publication)|
Objectives To determine whether pharmacy-based cardiovascular disease (CVD) screening reached the desired population, the local population's awareness of pharmacy screening and the views of service users and the general public about CVD screening. Methods: Pharmacy staff, located in one English Primary Care Trust providing a CVD screening service, issued questionnaires to service users who had undergone screening. Face-to-face street surveys were conducted with members of the general public within the vicinity of each participating pharmacy. Key findings A total of 259 people were screened within the first 6 months of service provision, 97 of whom (37.4%) completed the evaluation questionnaire. In addition, 261 non-service users participated in street surveys. Most respondents among both service users and non-users had at least one risk factor for cardiovascular disease, including smoking and lack of exercise. Responses to statements regarding CVD screening showed a high level of agreement with the need for screening in both groups. However, significantly more service users (90.7%) agreed that a pharmacy was a good place for screening compared to the non-users (77.4%; P < 0.005). Likewise significantly fewer service users agreed that screening should be only carried out by doctors (10.3 compared to 25.3% of non-users; P < 0.005). The overall majority of service users 96 (99.7%) had a positive experience of the screening service, agreeing that they were given enough time and pharmacists made them feel at ease. Only 9% of non-users were aware of the pharmacy service and, although the majority (78.4%) were willing to be screened at a pharmacy, this was significantly lower among males than females (69.9 compared to 82.7%; P < 0.005). Perceived concerns about confidentiality and lack of privacy were among barriers identified to taking up screening. Conclusion: Pharmacy-based CVD screening is acceptable to the public. Its uptake could be improved through increased awareness of the service and by addressing concerns about privacy and confidentiality in promotional activities.
|Uncontrolled keywords:||cardiovascular disease, community pharmacy services, public health, screening, adult, aged, alcohol consumption, cardiovascular risk, confidentiality, diet, drinking behavior, health status, lifestyle, pharmacist, pharmacy, privacy, smoking|
|Subjects:||R Medicine > RS Pharmacy and materia medica|
|Divisions:||Faculties > Science Technology and Medical Studies > Medway School of Pharmacy|
|Depositing User:||Janet Krska|
|Date Deposited:||19 Oct 2012 11:17|
|Last Modified:||11 Mar 2013 10:15|
|Resource URI:||http://kar.kent.ac.uk/id/eprint/31758 (The current URI for this page, for reference purposes)|
- Depositors only (login required):